SCYNEXIS INC. Files 10-Q for Q1 2025

Ticker: SCYX · Form: 10-Q · Filed: May 15, 2025 · CIK: 1178253

Scynexis Inc 10-Q Filing Summary
FieldDetail
CompanyScynexis Inc (SCYX)
Form Type10-Q
Filed DateMay 15, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, financials, SEC filing

TL;DR

SCYNEXIS INC. 10-Q filed. Financials updated for Q1 2025. Check warrants & stock units.

AI Summary

SCYNEXIS INC. filed a 10-Q for the period ending March 31, 2025. The filing details financial information, including assets and liabilities, and references various financial instruments such as warrants and restricted stock units. The company's business address is 1 Evertrust Plaza, 13th Floor, Jersey City, NJ.

Why It Matters

This filing provides investors with an update on SCYNEXIS INC.'s financial health and operational status as of the first quarter of 2025.

Risk Assessment

Risk Level: medium — 10-Q filings are standard for public companies, but the specific financial details and market conditions can introduce varying levels of risk.

Key Numbers

  • 20250331 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
  • 20250515 — Filing Date (The date the 10-Q was officially submitted to the SEC.)

Key Players & Entities

  • SCYNEXIS INC. (company) — Filer of the 10-Q
  • 20250331 (date) — End of reporting period
  • 20250515 (date) — Filing date
  • 1 Evertrust Plaza, 13th Floor, Jersey City, NJ 07302-6548 (address) — Company business and mail address
  • 201-884-5485 (phone_number) — Company business phone
  • us-gaap:WarrantMember (financial_instrument) — Mentioned financial instrument
  • us-gaap:AdditionalPaidInCapitalMember (financial_instrument) — Mentioned financial instrument
  • us-gaap:RestrictedStockUnitsRSUMember (financial_instrument) — Mentioned financial instrument

FAQ

What is the reporting period for this 10-Q filing?

The reporting period for this 10-Q filing is March 31, 2025.

When was this 10-Q filing submitted to the SEC?

This 10-Q filing was submitted to the SEC on May 15, 2025.

What is SCYNEXIS INC.'s business address?

SCYNEXIS INC.'s business address is 1 Evertrust Plaza, 13th Floor, Jersey City, NJ 07302-6548.

What are some of the financial instruments mentioned in the filing?

The filing mentions financial instruments such as warrants (us-gaap:WarrantMember), additional paid-in capital (us-gaap:AdditionalPaidInCapitalMember), and restricted stock units (us-gaap:RestrictedStockUnitsRSUMember).

What is the Standard Industrial Classification code for SCYNEXIS INC.?

The Standard Industrial Classification code for SCYNEXIS INC. is Pharmaceutical Preparations [2834].

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding SCYNEXIS INC (SCYX).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.